GH Research (GHRS) Other Working Capital Changes (2023 - 2025)
GH Research (GHRS) recorded quarterly Other Working Capital Changes of -$68000.0 in Q4 2025, down 3.03% quarter-over-quarter from -$66000.0 in Q3 2025, and down 15.25% on a YoY basis from -$80240.0 in Q4 2024.
GH Research (GHRS) Other Working Capital Changes (2023 - 2025) Analysis & Trends
GH Research's Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$68000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 15.25% year-over-year to -$68000.0; the TTM figure through Dec 2025 stood at -$197000.0 (up 35.2% YoY), while the FY2025 annual figure was -$197000.0, up 35.2% from the prior year.
- Other Working Capital Changes was -$68000.0 for Q4 2025 at GH Research, down from -$66000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$37000.0 in Q2 2023 to a low of -$114000.0 in Q2 2024.
- Historically, Other Working Capital Changes has averaged -$65454.5 across 3 years, with a median of -$63000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 208.11% in 2024, then surged 44.74% in 2025.
- A 3-year view of Other Working Capital Changes shows it stood at -$56000.0 in 2023, then fell by 5.36% to -$59000.0 in 2024, then fell by 15.25% to -$68000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$68000.0 (Q4 2025), -$66000.0 (Q3 2025), and -$63000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Sep 30, 2025 | -66,000.00 |
| Sep 30, 2025 | -66,000.00 |
| Jun 30, 2025 | -63,000.00 |
| Jun 30, 2025 | -63,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | -60,000.00 |
| Sep 30, 2024 | -60,000.00 |
| Jun 30, 2024 | -114,000.00 |
| Jun 30, 2024 | -114,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Dec 31, 2023 | -56,000.00 |
| Dec 31, 2023 | -56,000.00 |
| Sep 30, 2023 | -56,000.00 |
| Sep 30, 2023 | -56,000.00 |
| Jun 30, 2023 | -37,000.00 |
| Jun 30, 2023 | -37,000.00 |